Evaro
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Evaro - overview
Established
2017
Location
Norwich, -, UK
Primary Industry
Healthcare IT
About
Established in 2017 and based in Norwich, UK, Total Access Health Ltd. , dba Evaro, operates as a healthcare technology company that offers digital health solutions and healthcare accessibility. Thuria Wenbar (CEO) and Oskar Wendowski (CPO) are the co-founders of the company. In January 2026, Evaro raised GBP 18 million in series A funding led by Albion Capital, BBI, Exceptional Ventures, Simplyhealth Ventures, and Cornerstone VC.
Evaro generates revenue through a B2B pharmaceutical infrastructure-as-a-service model, enabling consumer brands to integrate prescription medication services seamlessly into their offerings. The company will use the January 2026 funding to scale its digital pharmacy infrastructure and expand regulated online care services with partners.
Current Investors
SyndicateRoom, University of East Anglia, Exceptional Ventures
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Application Integration Software
Website
www.evaro.com
Verticals
HealthTech, Mobile Apps, RegTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.